CTI BioPharma
CTIC
#5797
Rank
โ‚ฌ1.09 B
Marketcap
8,29ย โ‚ฌ
Share price
0.00%
Change (1 day)
37.53%
Change (1 year)

EPS for CTI BioPharma (CTIC)

EPS in 2023 (TTM): -0,56ย โ‚ฌ

According to CTI BioPharma 's latest financial reports the company's current EPS (TTM) is -0,53ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,77ย โ‚ฌ an increase over its 2021 EPS that were of -0,98ย โ‚ฌ.

EPS history for CTI BioPharma from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,56ย โ‚ฌ-28.26%
2022-0,77ย โ‚ฌ-21.3%
2021-0,98ย โ‚ฌ45.95%
2020-0,67ย โ‚ฌ7.25%
2019-0,63ย โ‚ฌ30.19%
2018-0,48ย โ‚ฌ-58.91%
2017-1,18ย โ‚ฌ-29.12%
2016-1,66ย โ‚ฌ-72.84%
2015-6,11ย โ‚ฌ6.35%
2014-5,74ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
4,79ย โ‚ฌ-1,005.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
28,16ย โ‚ฌ-5,426.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
15,84ย โ‚ฌ-3,096.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-1,29ย โ‚ฌ 143.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
1,91ย โ‚ฌ-462.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,12ย โ‚ฌ-879.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,41ย โ‚ฌ-177.59%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel